Low Spike Antibody Levels and Impaired BA.4/5 Neutralization in Patients with Multiple Myeloma or Waldenstrom’s Macroglobulinemia after BNT162b2 Booster Vaccination

SIMPLE SUMMARY: Upon BNT162b2 mRNA vaccinations, multiple myeloma (MM) and Waldenstrom’s macroglobulinemia (WM) patient cohorts on active therapy affecting B cell development had impaired binding and neutralizing antibody (NAb) response rate and magnitude to wildtype Wuhan (WA1). Patient cohorts on-...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosati, Margherita, Terpos, Evangelos, Bear, Jenifer, Burns, Robert, Devasundaram, Santhi, Ntanasis-Stathopoulos, Ioannis, Gavriatopoulou, Maria, Kastritis, Efstathios, Dimopoulos, Meletios-Athanasios, Pavlakis, George N., Felber, Barbara K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737406/
https://www.ncbi.nlm.nih.gov/pubmed/36497296
http://dx.doi.org/10.3390/cancers14235816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737406/
https://www.ncbi.nlm.nih.gov/pubmed/36497296
http://dx.doi.org/10.3390/cancers14235816

Ejemplares similares